Taking advantage of high-throughput sequencing techniques, extensive investigations have begun to uncover the mutational spectrum in other genes than BCR::ABL1 in CML already at CP diagnosis. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.